Literature DB >> 3075675

Effect of a kanpo medicine, zyuzentaihotô, on the immune reactivity of tumor-bearing mice.

M Hamada1, Y Fujii, H Yamamoto, Y Miyazawa, S M Shui, Y C Tung, N Yamaguchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3075675     DOI： 10.1016/0378-8741(88)90160-2

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN： 0378-8741            Impact factor:   4.360


× No keyword cloud information.
  5 in total

1.  Oral administration of a Kampo (Japanese herbal) medicine Juzen-taiho-to inhibits liver metastasis of colon 26-L5 carcinoma cells.

Authors:  Y Ohnishi; H Fujii; Y Hayakawa; R Sakukawa; T Yamaura; T Sakamoto; K Tsukada; M Fujimaki; S Nunome; Y Komatsu; I Saiki
Journal:  Jpn J Cancer Res       Date:  1998-02

2.  Inhibitory effect of a traditional Chinese medicine, Juzen-taiho-to, on progressive growth of weakly malignant clone cells derived from murine fibrosarcoma.

Authors:  Y Ohnishi; H Fujii; F Kimura; T Mishima; J Murata; K Tazawa; M Fujimaki; F Okada; M Hosokawa; I Saiki
Journal:  Jpn J Cancer Res       Date:  1996-10

Review 3.  Recent Advances in Glycyrrhiza glabra (Licorice)-Containing Herbs Alleviating Radiotherapy- and Chemotherapy-Induced Adverse Reactions in Cancer Treatment.

Authors:  Kai-Lee Wang; Ying-Chun Yu; Hsin-Yuan Chen; Yi-Fen Chiang; Mohamed Ali; Tzong-Ming Shieh; Shih-Min Hsia
Journal:  Metabolites       Date:  2022-06-09

4.  IL-12 and IL-18 induction and subsequent NKT activation effects of the Japanese botanical medicine Juzentaihoto.

Authors:  Kazuhiko Fujiki; Masanori Nakamura; Takako Matsuda; Mariko Isogai; Minako Ikeda; Yutaka Yamamoto; Mari Kitamura; Naoko Sazaki; Fumiatsu Yakushiji; Shinji Suzuki; Junji Tomiyama; Takashi Uchida; Ken Taniguchi
Journal:  Int J Mol Sci       Date:  2008-07-08       Impact factor: 6.208

5.  The long-term effects of a kampo medicine, juzentaihoto, on maintenance of antibody titer in elderly people after influenza vaccination.

Authors:  Ikuo Saiki; Keiichi Koizumi; Hirozo Goto; Akiko Inujima; Takao Namiki; Masaki Raimura; Toshiaki Kogure; Takeshi Tatsumi; Hiroki Inoue; Shinya Sakai; Hiroshi Oka; Makoto Fujimoto; Hiroaki Hikiami; Hiroaki Sakurai; Naotoshi Shibahara; Yutaka Shimada; Hideki Origasa
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-18       Impact factor: 2.629
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.